Transamerica Financial Advisors’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24 Sell
8
-31
-79% -$105 ﹤0.01% 2176
2026
Q1
$163 Hold
39
﹤0.01% 1670
2025
Q4
$168 Buy
39
+3
+8% +$11 ﹤0.01% 1564
2025
Q3
$156 Buy
+36
New +$162 ﹤0.01% 1468

Other funds holding SBC

Transamerica Financial Advisors's SBC Position: Q2 2026 in Review

Transamerica Financial Advisors reduced its SBC Medical Group (SBC) stake by 79% in Q2 2026, selling an estimated $105 and leaving 8 shares worth $24. The position accounts for ﹤0.01% of the portfolio, ranked #2176.

Transamerica Financial Advisors first reported a position in SBC in Q3 2025 and has held it in 4 quarters since. The position peaked at $168 in Q4 2025. 57 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • Transamerica Financial Advisors held 8 shares of SBC Medical Group worth $24 as of Q2 2026.
  • Transamerica Financial Advisors sold 31 SBC Medical Group shares in Q2 2026, an estimated $105.
  • SBC Medical Group made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #2176 holding.
  • Transamerica Financial Advisors first reported a position in SBC Medical Group in Q3 2025 and has held it in 4 quarters since.
  • Transamerica Financial Advisors's SBC Medical Group position peaked at $168 in Q4 2025.
  • 57 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.